SPARK is recruiting at Analyst through Senior Associate” level – prior experience essential

SPARK Advisory Partners is actively recruiting at Analyst through to Senior Associate level in its London office due to exceptional growth. We are inviting applications from individuals with between two and six years’ experience of working in the corporate finance advisory function of a firm with Nominated Adviser and/or Sponsor status. The individual should be […]

SPARK has acted as Financial and Nominated Adviser to MyHealthChecked plc in respect of its Placing and Subscription

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it has acted as Financial and Nominated Adviser to MyHealthChecked plc (“MHC”) in respect of its Placing and Subscription for £3.4m of new ordinary shares. MHC is seeking to become the UK’s leading business-to-consumer testing business addressing the high growth structural shift from consumers to use […]

SPARK acts as Sponsor to Draper Esprit VCT plc

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it has acted as Sponsor to Draper Esprit VCT Plc (“DEVC”) in respect of its Offer for Subscription of £5m of new ordinary shares (with up to a further £15m over-allotment facility). If the offer is taken up in full (including the over-allotment facility), once invested, […]

SPARK acts as financial adviser to Two Shields Investments plc on reverse takeover of BrandShield Limited

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it acted as Financial Adviser and Nominated Adviser to Two Shields Investments plc in respect of its successful all-share reverse takeover of BrandShield Limited. This valued BrandShield at £13.1 million and was accompanied by a £3.2 million placing. The enlarged Group has been renamed BrandShield Systems […]

SPARK acts as Sponsor to Seneca Growth Capital VCT Plc

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it has acted as Sponsor to Seneca Growth Capital VCT Plc (“SVCT”) in respect of its Offer for Subscription of £10m of B Shares (with up to a further £10m over-allotment facility). This offer follows the success of SVCT’s B Share offer launched in 2018 (which […]

SPARK acts as Sponsor to Downing ONE VCT plc

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it has acted as Sponsor to Downing ONE VCT plc in respect of its proposed Offer for Subscription of £15m (with up to a further £25m over-allotment facility). Downing ONE VCT is a well-established venture capital trust (VCT), created by the merger of six VCTs managed […]

SPARK acts as Financial Adviser to Integumen plc (to be renamed Deepverge plc) in respect of its recommended all share offer for Modern Water plc

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it is acting as Financial Adviser to Integumen plc in respect of its proposed all share Offer to acquire the whole of the issued share capital of Modern Water plc (“MW”). This values Modern Water at £21.25 million. The Rule 2.7 announcement (under the City Code […]

SPARK appointed Financial and Nominated Adviser to Equatorial Palm Oil plc

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it has been appointed as financial and nominated adviser to Equatorial Palm Oil plc. Equatorial Palm Oil plc is an AIM listed company. Following disposal of its Liberian Palm Oil assets in June, EPO is an “AIM Rule 15 cash shell” and, as such, is required […]

SPARK appointed as Nominated Adviser to Redx Pharma plc

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it has been appointed as nominated adviser to AIM quoted Redx Pharma plc. Redx Pharma Plc (AIM ticker: REDX) engages in drug discovery, pre-clinical development, and licensing activities in the United Kingdom.

SPARK acts as Sponsor to Cathay International Holdings Limited

SPARK Advisory Partners Limited (“SPARK”) is pleased to announce it has acted as Sponsor to Cathay International Holdings Limited in respect of its proposed USD130m equity fundraising, comprising an Open Offer to existing shareholders and a Subscription to new investors, Class 1 Disposal of shares in Zhejiang Starry Pharmaceuticals and transfer of listing category. The […]